PTHS · Categories · Form 4
PTHS - SEC Form 4 insider transactions
Pelthos Therapeutics Inc. (PTHS) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for PTHS
- CFO, Treas & Secty Francis Knuettel Ii returned 13,947 shares to the company and sold $40,265 worth of shares (1,500 units at $26.84), decreasing direct ownership by 42% to 19,525 units (SEC Form 4)4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
- Director Friedberg Ezra M covered exercise/tax liability with 144 shares, decreasing direct ownership by 0.18% to 81,883 units (SEC Form 4) (withholding obligation)4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
- SEC Form 4 filed by Malamut Richard4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
- SEC Form 4 filed by Friedberg Ezra M4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
- SEC Form 4 filed by Pauls Matthew4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
- SEC Form 4 filed by Greenleaf Peter4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
- Amendment: SEC Form 4 filed by Friedberg Ezra M4/A - Pelthos Therapeutics Inc. (0001919246) (Issuer)
- Amendment: SEC Form 4 filed by Davis Todd C4/A - Pelthos Therapeutics Inc. (0001919246) (Issuer)
- Amendment: SEC Form 4 filed by Malamut Richard4/A - Pelthos Therapeutics Inc. (0001919246) (Issuer)
- Amendment: SEC Form 4 filed by Plesha Scott M.4/A - Pelthos Therapeutics Inc. (0001919246) (Issuer)
- Amendment: SEC Form 4 filed by Greenleaf Peter4/A - Pelthos Therapeutics Inc. (0001919246) (Issuer)
- Amendment: SEC Form 4 filed by Pauls Matthew4/A - Pelthos Therapeutics Inc. (0001919246) (Issuer)
- Amendment: SEC Form 4 filed by Rangarao Sai4/A - Pelthos Therapeutics Inc. (0001919246) (Issuer)
- Amendment: SEC Form 4 filed by Baxter Richard B4/A - Pelthos Therapeutics Inc. (0001919246) (Issuer)
- Amendment: SEC Form 4 filed by Francis Knuettel Ii4/A - Pelthos Therapeutics Inc. (0001919246) (Issuer)
- Director Einhorn Andrew J. was granted 12,000 shares (SEC Form 4)4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
- Director Pauls Matthew converted options into 10,616 shares and gifted 9,542 shares (SEC Form 4)4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
- Director Friedberg Ezra M sold $280,280 worth of shares (10,000 units at $28.03) (SEC Form 4)4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
- SEC Form 4 filed by Director Ligand Pharmaceuticals Inc4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
- SEC Form 4 filed by CEO and President Plesha Scott M.4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
- SEC Form 4 filed by Chief Commercial Officer Rangarao Sai4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)